- Home
- KG vs CATX Comparison
KG vs CATX Comparison
Compare KG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- CATX
- Stock Information
- Founded
- KG N/A
- CATX 1983
- Country
- KG Bermuda
- CATX United States
- Employees
- KG N/A
- CATX N/A
- Industry
- KG Property-Casualty Insurers
- CATX Medical/Dental Instruments
- Sector
- KG Finance
- CATX Health Care
- Exchange
- KG Nasdaq
- CATX Nasdaq
- Market Cap
- KG 225.0M
- CATX 239.0M
- IPO Year
- KG N/A
- CATX N/A
- Fundamental
- Price
- KG $25.84
- CATX $3.66
- Analyst Decision
- KG
- CATX Strong Buy
- Analyst Count
- KG 0
- CATX 10
- Target Price
- KG N/A
- CATX $12.90
- AVG Volume (30 Days)
- KG 45.8K
- CATX 790.0K
- Earning Date
- KG 11-15-2025
- CATX 11-11-2025
- Dividend Yield
- KG N/A
- CATX N/A
- EPS Growth
- KG N/A
- CATX N/A
- EPS
- KG 9.13
- CATX N/A
- Revenue
- KG $9,983,137.00
- CATX $1,235,000.00
- Revenue This Year
- KG N/A
- CATX N/A
- Revenue Next Year
- KG N/A
- CATX N/A
- P/E Ratio
- KG $2.81
- CATX N/A
- Revenue Growth
- KG 250.18
- CATX N/A
- 52 Week Low
- KG $20.51
- CATX $1.60
- 52 Week High
- KG $36.80
- CATX $13.56
- Technical
- Relative Strength Index (RSI)
- KG 40.59
- CATX 57.90
- Support Level
- KG $25.47
- CATX $3.33
- Resistance Level
- KG $27.75
- CATX $3.58
- Average True Range (ATR)
- KG 1.08
- CATX 0.23
- MACD
- KG -0.20
- CATX 0.05
- Stochastic Oscillator
- KG 10.11
- CATX 84.21
About KG Kestrel Group Ltd.
Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.